The FDA has approved Epioxa™ HD 0.239% and Epioxa™ 0.177% for use in epithelium-on corneal collagen CXL for the treatment of ...
The Food and Drug Administration has approved Eydenzelt (aflibercept-boav), a biosimilar to Eylea (aflibercept).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback